Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chung-En Ni"'
Publikováno v:
BMC Medical Genomics, Vol 16, Iss S2, Pp 1-17 (2023)
Abstract Background Cell composition deconvolution (CCD) is a type of bioinformatic task to estimate the cell fractions from bulk gene expression profiles, such as RNA-seq. Many CCD models were developed to perform linear regression analysis using re
Externí odkaz:
https://doaj.org/article/8c8d6b672d5d4def8b25bab716326e0a
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15736-15760 (2023)
Abstract Background Many studies have utilized computational methods, including cell composition deconvolution (CCD), to correlate immune cell polarizations with the survival of cancer patients, including those with hepatocellular carcinoma (HCC). Ho
Externí odkaz:
https://doaj.org/article/2630582e5181474fb55d463a0820f9c2
Autor:
Chung-En Ni, 倪崇恩
106
Carbapenem-resistant Enterobacteriaceae (CRE) are emerging life-threating pathogens which can cause serious infectious diseases. So far, little is known about how certain strains could be both drug-resistant (DRE) and hyper-virulent (HV). In
Carbapenem-resistant Enterobacteriaceae (CRE) are emerging life-threating pathogens which can cause serious infectious diseases. So far, little is known about how certain strains could be both drug-resistant (DRE) and hyper-virulent (HV). In
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/t22ajc
Publikováno v:
2022 IEEE 22nd International Conference on Bioinformatics and Bioengineering (BIBE).
Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan
Autor:
Yen Hua Huang, Chung En Ni, Tsuey Ching Yang, Sheng Hua Chou, Syun Wun Liang, Yi Tsung Lin, Yi Wei Huang
Publikováno v:
Journal of Antimicrobial Chemotherapy. 73:2039-2046
Background Carbapenemase-producing Klebsiella pneumoniae causes high mortality owing to the limited therapeutic options available. Here, we investigated an emergent carbapenem-resistant K. pneumoniae strain with hypervirulence found among KPC-2-produ
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO3-9